The prescription-only IB-Stim device is a small, battery-powered electrical nerve stimulator that is placed behind the ear and emits low-frequency electrical pulses to stimulate branches of cranial nerves, a technique believed to provide pain relief. The single-use device is worn for five days before being replaced, and can be used consistently for up to three weeks.
The FDA’s clearance came after a clinical study showed that adolescent IBS patients who used the device to treat their abdominal pain experienced significant decreases in their pain over the course of three weeks. IB-Stim can be used in tandem with a patient’s existing medication regimen for IBS-related chronic abdominal pain.
More articles about health IT:
Cleveland Clinic study finds electronic inhaler usage reduces COPD-related hospitalizations
Most health system CFOs lack agreeable cooperation with CIOs, survey finds
Google’s 5 latest health-related job openings
